Comment
doi: 10.1056/NEJMc2110093.
Epub 2021 Jul 21.
ChAdOx1 nCoV-19 Vaccine Efficacy against the B.1.351 Variant. Reply
Affiliations
- PMID: 34289271
- DOI: 10.1056/NEJMc2110093
Item in Clipboard
Comment
ChAdOx1 nCoV-19 Vaccine Efficacy against the B.1.351 Variant. Reply
N Engl J Med.
.
No abstract available
Comment on
-
ChAdOx1 nCoV-19 Vaccine Efficacy against the B.1.351 Variant.N Engl J Med. 2021 Aug 5;385(6):571. doi: 10.1056/NEJMc2110093. Epub 2021 Jul 21. N Engl J Med. 2021. PMID: 34289270 No abstract available.
Similar articles
-
ChAdOx1 nCoV-19 Vaccine Efficacy against the B.1.351 Variant.N Engl J Med. 2021 Aug 5;385(6):571. doi: 10.1056/NEJMc2110093. Epub 2021 Jul 21. N Engl J Med. 2021. PMID: 34289270 No abstract available.
-
Hypothesis: Possible influence of antivector immunity and SARS-CoV-2 variants on efficacy of ChAdOx1 nCoV-19 vaccine.Br J Pharmacol. 2022 Jan;179(2):218-226. doi: 10.1111/bph.15620. Epub 2021 Jul 31. Br J Pharmacol. 2022. PMID: 34331459 Free PMC article.
-
ChAdOx1 nCoV-19 vaccine: asymptomatic efficacy estimates - Authors' reply.Lancet. 2021 Jun 12;397(10291):2248. doi: 10.1016/S0140-6736(21)00976-4. Lancet. 2021. PMID: 34119059 No abstract available.
-
MOG encephalomyelitis after vaccination against severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2): case report and comprehensive review of the literature.J Neurol. 2022 Oct;269(10):5198-5212. doi: 10.1007/s00415-022-11194-9. Epub 2022 Jun 23. J Neurol. 2022. PMID: 35737110 Free PMC article. Review.
-
Herpes simplex encephalitis following ChAdOx1 nCoV-19 vaccination: a case report and review of the literature.BMC Infect Dis. 2022 Mar 3;22(1):217. doi: 10.1186/s12879-022-07186-9. BMC Infect Dis. 2022. PMID: 35241013 Free PMC article. Review.
Cited by
-
Salivary, serological, and cellular immune response to the CoronaVac vaccine in health care workers with or without previous COVID-19.Sci Rep. 2022 Jun 16;12(1):10125. doi: 10.1038/s41598-022-14283-x. Sci Rep. 2022. PMID: 35710573 Free PMC article.
-
Effectiveness of Naturally Acquired and Vaccine-Induced Immune Responses to SARS-CoV-2 Mu Variant.Emerg Infect Dis. 2022 Aug;28(8):1708-1712. doi: 10.3201/eid2808.220584. Epub 2022 Jul 13. Emerg Infect Dis. 2022. PMID: 35830278 Free PMC article.
-
Post-Vaccination Coronavirus Disease 2019: A Case-Control Study and Genomic Analysis of 119 Breakthrough Infections in Partially Vaccinated Individuals.Clin Infect Dis. 2022 Aug 25;75(2):305-313. doi: 10.1093/cid/ciab714. Clin Infect Dis. 2022. PMID: 34410361 Free PMC article.
-
Resilience of Spike-Specific Immunity Induced by COVID-19 Vaccines against SARS-CoV-2 Variants.Biomedicines. 2022 Apr 26;10(5):996. doi: 10.3390/biomedicines10050996. Biomedicines. 2022. PMID: 35625733 Free PMC article.
-
[The corona pandemic and multiple sclerosis: vaccinations and their implications for patients-Part 2: vaccine technologies].Nervenarzt. 2021 Dec;92(12):1283-1292. doi: 10.1007/s00115-021-01154-5. Epub 2021 Jul 7. Nervenarzt. 2021. PMID: 34232358 Free PMC article. Review. German.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
